Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
View ORCID ProfileWadim Koslow, View ORCID ProfileMartin J. Kühn, View ORCID ProfileSebastian Binder, View ORCID ProfileMargrit Klitz, View ORCID ProfileDaniel Abele, Achim Basermann, Michael Meyer-Hermann
doi: https://doi.org/10.1101/2021.07.09.21260257
Wadim Koslow
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Martin J. Kühn
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Sebastian Binder
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig,Germany
Margrit Klitz
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Daniel Abele
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Achim Basermann
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Michael Meyer-Hermann
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig,Germany
Data Availability
The parameters to setup the simulations are provided in the current article and [6]. The simulation output for all different strategies, scenarios and Monte Carlo runs presented here make up multiple GBs cannot be shared easily. Particular results can be shared upon request. Intra- and intercounty contact and raw, non-normalized mobility data for initialization are provided in https://www.medrxiv.org/content/10.1101/2021.04.23.21255995v1.supplementary-material.
Posted July 14, 2021.
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
Wadim Koslow, Martin J. Kühn, Sebastian Binder, Margrit Klitz, Daniel Abele, Achim Basermann, Michael Meyer-Hermann
medRxiv 2021.07.09.21260257; doi: https://doi.org/10.1101/2021.07.09.21260257
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
Wadim Koslow, Martin J. Kühn, Sebastian Binder, Margrit Klitz, Daniel Abele, Achim Basermann, Michael Meyer-Hermann
medRxiv 2021.07.09.21260257; doi: https://doi.org/10.1101/2021.07.09.21260257
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)